TY - JOUR
T1 - Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft
AU - Bar-Shira, Anat
AU - Pinthus, Jehonathan H.
AU - Rozovsky, Uri
AU - Goldstein, Myriam
AU - Sellers, William R.
AU - Yaron, Yuval
AU - Eshhar, Zelig
AU - Orr-Urtreger, Avi
PY - 2002/12/1
Y1 - 2002/12/1
N2 - We analyzed a prostate cancer xenograft derived from a locally advanced tumor using combined cytogenetic, array-based comparative genomic hybridization and expression analyses. This analysis revealed that genes in the 20q13 chromosomal region, CSE1L, ZNF217, MYBL2, and STK15, were significantly overexpressed in this tumor. The expression pattern of these genes was then confirmed in two large human prostate cancer microarray databases. Furthermore, the MYBL2 and STK15 have been significantly overexpressed in prostate metastases, allowing a clear distinction between localized tumors and metastases. Our data suggest these genes to be involved in advanced stages of prostate tumorigenesis and as such, they may serve as markers for tumor progression.
AB - We analyzed a prostate cancer xenograft derived from a locally advanced tumor using combined cytogenetic, array-based comparative genomic hybridization and expression analyses. This analysis revealed that genes in the 20q13 chromosomal region, CSE1L, ZNF217, MYBL2, and STK15, were significantly overexpressed in this tumor. The expression pattern of these genes was then confirmed in two large human prostate cancer microarray databases. Furthermore, the MYBL2 and STK15 have been significantly overexpressed in prostate metastases, allowing a clear distinction between localized tumors and metastases. Our data suggest these genes to be involved in advanced stages of prostate tumorigenesis and as such, they may serve as markers for tumor progression.
UR - http://www.scopus.com/inward/record.url?scp=0036894571&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 12460888
AN - SCOPUS:0036894571
SN - 0008-5472
VL - 62
SP - 6803
EP - 6807
JO - Cancer Research
JF - Cancer Research
IS - 23
ER -